Millavelez, Cris .

HRN: 28-85-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
04/17/2026
04/24/2026
PO
4ml
BID
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: